A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 211
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Dpyr
Long Form : deoxypyridinoline
No. Year Title Co-occurring Abbreviation
1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. Pyr
1992 The effect of rat parathyroid hormone (1-34) infusion on urinary 3-hydroxypyridinium cross-link excretion in the rat. Pyr
1992 Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. Pyr
1993 Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects. Pyr
1993 Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography. PFPA, Pyr
1993 Changes of bone metabolic markers in patients with bone metastases: clinical significance in assessing bone response to chemotherapy. ALP, BM, Hyp, Pyr
1993 Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. HPLC, Ides, Pyr
1993 Impairment of bone turnover in elderly women with hip fracture. Pyr
1993 Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Pyr, RA
10  1993 Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? Pyr
11  1993 [Pyridinoline and deoxypyridinoline excretion in urine of healthy children--dependence on age]. BMC, Pyr
12  1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. Cr, ELISA, Pyr
13  1994 Comparison of immuno- and HPLC-assays for the measurement of urinary collagen cross-links. Pyr
14  1994 Determination of pyridinium crosslinks in plasma and serum by high-performance liquid chromatography. Pyr
15  1994 Effect of salmon calcitonin on deoxypyridinoline (Dpyr) urinary excretion in healthy volunteers. Pyr, SMC
16  1994 Evaluation and comparison of urinary pyridinium crosslinks in two rat models of bone loss--ovariectomy and adjuvant polyarthritis--using a new automated HPLC method. BMD, Pyr
17  1994 Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat. Pyr
18  1994 Markers of bone metabolism during short-term administration of thyroxine in healthy volunteers. BAP, BGP, Pyr
19  1994 The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. ELISA, F-Pyr, HPLC, Pyr
20  1994 The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. BUA, Pyr, SOS
21  1994 The Urinary Excretion of Pyridinium Cross-links as Markers of Bone Meta stasisin Breast Cancer. Pyr
22  1994 Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. MP, Pyr
23  1994 Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Pyr
24  1994 [Assay of urinary pyridinoline and deoxypyridinoline as potential markers of the rate of bone resorption: usefulness of urinary pyridinoline and deoxypyridinoline in patients with prostate cancer with bone metastases]. ALP, BGP, BPH, HPLC, Pyr
25  1995 Bone mineral density and bone turnover in spinal osteoarthrosis. BAP, BMD, CI, FN, LS, OA, TB
26  1995 Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. BMC, Cr, Tb.Th
27  1995 Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. BGP, PICP, Pyr
28  1995 Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Pyr
29  1995 Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissues using high-performance liquid chromatography. PEN, Pyr
30  1995 Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. BAP, Hyp, Pyr, TAP, TRAP
31  1995 Estimation of bone mineral density and bone loss by means of bone metabolic markers in postmenopausal women. ALP, BMD, DXA, Pyr
32  1995 Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. BMD, HRT, OC, RA
33  1995 The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism. BMD, DEXA, hOC
34  1995 Urinary excretion of deoxypyridinoline in patients with breast cancer. ---
35  1995 Urinary pyridinoline and deoxypyridinoline excretion in children. Pyr
36  1995 Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. Pyr
37  1995 [Measurement and clinical significance of serum concentrations of pyridinium cross-links in patients with renal osteodystrophy]. Pyr
38  1996 Biochemical bone markers in patients with multiple myeloma. BSALP, Ca, Cr, MM, OC, TRAP
39  1996 Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. pro-I-CPP, Pyr, RA
40  1996 Concentrations of pyridinoline and deoxypyridinoline in joint tissues from patients with osteoarthritis or rheumatoid arthritis. NA, OA, Pyr, RA
41  1996 Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin. Ca, Pyr
42  1996 Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy. GGHyl, GHYL, HRT, Pyr
43  1996 Hip bone mineral density is improved by high-impact aerobic exercise in postmenopausal women and men over 50 years. BMD, Pyr
44  1996 Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application. GH, GV, hGH, Pyr
45  1996 Serum and urine markers of type I collagen metabolism in elderly women with high and low bone mineral density. BMD, Pyr
46  1996 The effect of tamoxifen on bone metabolism and skeletal growth is different in ovariectomized and intact rats. BMC, BMD, DXA, Pyr, TAM
47  1996 The renal clearance of free and conjugated pyridinium cross-links of collagen. HPLC, Pyr
48  1996 To determine the effects of ultraviolet light, natural light and ionizing radiation on pyridinium cross-links in bone and urine using high-performance liquid chromatography. Pyr, UV
49  1996 [Bone resorption markers]. ICTP, Pyr
50  1996 [Changes in bone mineral content and bone metabolism during pregnancy and puerperium]. Ca, CRE, iCa, iOC, iPTH, Pyr
51  1996 [Usefulness of estriol for the treatment of bone loss in postmenopausal women]. BMD, Ca, DXA, Pyr
52  1997 A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. GHYL
53  1997 A population-based study of the relationship between salt intake, bone resorption and bone mass. ---
54  1997 Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. EDS VI, Pyr
55  1997 Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. ALP, BMD, OC
56  1997 Assessment of different markers of bone resorption in postmenopausal osteoporotic women treated with pamidronate. Pyr
57  1997 Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administration. GnRHa, Pyr
58  1997 Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Pyr
59  1997 Diagnostic validity of bone metabolic markers for bone metastasis. ALP, Pyr, ROC
60  1997 Discrimination ability of pyridinoline crosslinks related markers for bone resorption in postmenopause and osteoporosis. ICTP, POST, PRE, Pyr, ROC
61  1997 Effect of thyroid hormone on bone and mineral metabolism in rat: evaluation by biochemical markers. ALP, BMD, OC, Pyr
62  1997 Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. BMD, ESR, PMR, Pyr
63  1997 Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. BMD
64  1997 Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats. BW, IND, MAR, MTX
65  1997 Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast. Pyr
66  1997 Rectal steroids suppress bone formation in patients with colitis. BALP, PICP
67  1997 Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. AI, Hyp, PICP, Pyr
68  1997 Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism. ALP, BGP, PHP, Pyr, SHP
69  1998 Automated on-line solid-phase extraction and high-performance liquid chromatographic analysis of total and free pyridinium crosslinks in serum. pM, Pyr
70  1998 Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment. BALP, BMD, HRT, OC
71  1998 Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. bAP, BMD, FN, IGF-I, LS
72  1998 Bone turnover in amenorrhoeic and eumenorrhoeic women distance runners. AmR, BAP, EB, EE, EI, EuR, OC, P1CP, Pyr, SC
73  1998 Changes in urinary excretion of deoxypyridinoline in tail-suspended rats: effects of a bisphosphonate, YH529. ---
74  1998 Changes of biochemical markers during fracture healing. ELISA, HPLC, Pyr, RIA
75  1998 Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. FV, HPLC, Pyr
76  1998 Collagen-derived markers of bone metabolism in osteogenesis imperfecta. OI, Pyr, SDS-PAGE
77  1998 Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Hyp, PBC, PIIINP, Pyr, TRAP
78  1998 Differential time-related effects of conjugated equine estrogen on bone metabolism in oophorectomized women. BMD, CEE, DEXA, ERT, hOC
79  1998 Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency. BMD, FN, GHD, LS, OC, PICP
80  1998 Evaluation of osteocalcin and pyridinium crosslinks of bone collagen as markers of bone turnover in gingival crevicular fluid during different stages of orthodontic treatment. HPLC, OC, Pyr
81  1998 Inter and intra-individual variations in urinary excretion of pyridinium crosslinks of collagen in healthy young adults. Pyr
82  1998 Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. BM, G-CSF, HPC
83  1998 Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. BAP
84  1998 Responsiveness of urinary markers of bone resorption to orchiectomy and clodronate treatment in mature rats: a comparative study. BMD, GGHyl, GHYL, Pyr
85  1998 Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults. BAP, BMD, DEXA, GHD, OC, Pyr
86  1998 Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. ALP, sIL-6R
87  1998 Sex steroids, bone turnover and bone mineral density in pre-, peri-, and postmenopausal women. BMD, I-BGP, SHBG
88  1998 The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover. ALP, GnRHa, Hpr, OC, Pyr
89  1998 The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption. Hpr, HRT, Pyr
90  1998 The less potent estrogenic effect of tamoxifen on bone in ovariectomized rats with established osteopenia. BMC, BMD, DXA, Pyr, TAM
91  1998 The preventive and interventional effects of raloxifene analog (LY117018 HCL) on osteopenia in ovariectomized rats. BMC, BMD, Pyr
92  1998 Urinary collagen crosslinks reflect further bone loss of femoral neck in osteoporotic patients undergoing vitamin D therapy. ALP, BMD, Hyp, Pyr
93  1998 Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis. HRT
94  1998 Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Pyr
95  1998 [Biochemical markers of bone remodeling in the prevention of postmenopausal osteoporosis]. Pyr
96  1998 [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels]. ALP, BPH, PCa
97  1999 Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. BMD, BSAP, N-MID OC
98  1999 Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. AS, BMD, PTH, Pyr
99  1999 Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study. ALP, BGP, BMD, Ca, Pyr
100  1999 Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. BALP, OC, Pyr
101  1999 Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. BALP, CT, Pyr
102  1999 Biochemical markers of bone turnover during hormone replacement therapy. HRT, OC, Pyr
103  1999 Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report. BALP, BC, OC, Pyr, ROC
104  1999 Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. ALP, BMD, DEXA, HPLC, Pyr, TSH
105  1999 Changes in bone resorption during the menstrual cycle. BAP, FP, OC
106  1999 Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. CTX, HPLC, OA, Pyr, RA
107  1999 Correlation of quantitative ultrasound of bone with biochemical markers of bone resorption in women with osteoporotic fractures. BUA, Pyr, QUS, SOS
108  1999 Effect of recombinant human growth hormone in elderly osteoporotic women. BMD, GH, IGFBP-3, OC
109  1999 Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer. DXA, Pyr
110  1999 Evaluation of bone metabolism after the use of an inhaled glucocorticoid (flunisolide) in patients with moderate asthma. OC, Pyr
111  1999 Immobilization-dependent bone collagen breakdown appears to increase with time: evidence for a lack of new bone equilibrium in response to reduced load during prolonged bed rest. BALP, ICTP, Pyr
112  1999 Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases. Pyr
113  1999 Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. BALP, mFPG, OC
114  1999 Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. AR, Ca, OC, Pyr
115  1999 The effect of moderately and severely restricted dietary magnesium intakes on bone composition and bone metabolism in the rat. Pyr
116  1999 Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutic effects of estrogen and alfacalcidol in women with osteoporosis. BMD, Pyr
117  1999 [Monitoring markers of bone turnover in multiple myeloma]. HPLC, OC, Pyr
118  2000 Activity of rheumatoid arthritis and urinary pyridinoline and deoxypyridinoline. BMD, CRP, Pyr, RA
119  2000 Biochemical markers and bone mineral density in patients with hip fractures in men. BMD, DHEAS, LH, Pyr, Te
120  2000 Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma. BAP, IL-6, Pyr, TGF, TNF
121  2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. BAP, BMD, DHEA, PTH, RR, SHBG
122  2000 Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis. BMD, GOA, KOA, Pyr
123  2000 Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: decrease during osteoporosis and link to bone markers with specific isoform involvement. CTR, OsteoP, Pre-M, sBAP
124  2000 Changes in calcium, PTH and 1,25(OH)2 vitamin D3 during tail-suspension in ovariectomized rats: effects of estrogen administration. PTH
125  2000 Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition. iOC, Pyr
126  2000 Direct detection of crosslinks of collagen and elastin in the hydrolysates of human yellow ligament using single-column high performance liquid chromatography. DES, PEN, Pyr
127  2000 Effects of short-term administration of growth hormone in healthy young men, women, and women taking oral contraceptives. GH, IGF-1, LDL, OCs, SHBG
128  2000 Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Pyr, SHBG
129  2000 Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. 11beta-HSD, Pyr, RT-PCR
130  2000 Isometric progressive resistive exercise for osteoporosis. ALP
131  2000 Milk basic protein: a novel protective function of milk against osteoporosis. BMD, MBP, sham
132  2000 Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. RH, SHBG
133  2000 Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. BSAP, OC
134  2000 Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor. AA, MMP, Pyr
135  2000 The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia. BMC, BMD, DXA, ND, Pyr
136  2000 The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. OC, PICP, Pyr
137  2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. BMD
138  2001 Bone metabolism and body composition in Japanese patients with active acromegaly. BMD, OC
139  2001 Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: a short-term model for evaluation of antiresorptive therapy. BMD, GnRH, GnRHa
140  2001 Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. BMD, BMI, OC
141  2001 Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism. ALP, Ca
142  2001 Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism. ALP, BFR, iOC, MAR, O.Th, PICP, TRAP
143  2001 Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. BMD, PHPT, PTH
144  2001 Effects of short-term use of ibuprofen or acetaminophen on bone resorption in healthy men: a double-blind, placebo-controlled pilot study. NSAIDs
145  2001 Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. FTIR, Hcys, Pyr
146  2001 Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Pyr, stPyr
147  2001 Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis. PTH
148  2001 No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Cr, Pyr, RVAU
149  2001 Osteoporosis in men: a potential role for the sex hormone binding globulin. BMD, BMI, BSAP, CI, SHBG
150  2001 Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. BSP, DEXA, LS-BMD, Pyr
151  2001 Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis. BMD, BSALP, HRT, tALP
152  2001 The effect of calcium intake on bone composition and bone resorption in the young growing rat. Pyr
153  2001 [Can sleep urine calcium concentration corrected by osmolality as a screening test identify subjects with risk to develop osteoporosis?]. Ca, Cr, Osm, Pyr
154  2002 Biological variability of biochemical markers of bone turnover in healthy women. BAP, iPTH, Pyr, U-CTX
155  2002 Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. AI, ALP, BALP, BMD, CS, DEXA, Pyr
156  2002 Bone resorption versus estrogen loss following oophorectomy and menopause. BMD, Cr, ICTP, Pyr
157  2002 Does active treatment of rheumatoid arthritis limit disease-associated bone loss? DAS, DMARDs, Pyr, RA
158  2002 Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. B-ALP, BGP, BMD, HRT, Pyr
159  2002 Olpadronate prevents the bone loss induced by cyclosporine in the rat. BALP, BMD, OPD
160  2002 Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. IGFBP-III, IGFBP-III, Pyr
161  2002 Pregnancy and lactation affect markers of calcium and bone metabolism differently in adolescent and adult women with low calcium intakes. BAP, iPTH
162  2002 Relationship of bone turnover parameters, endogenous hormones and vit D deficiency to hip fracture in elderly postmenopausal women. iPTH, T-ALP and B-ALP
163  2002 Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers. CRP, ESR, RA
164  2002 The efficacy of two dosages of a continuous combined hormone replacement regimen. HDL-C, HRT, LDL-C, NETA, TC, TG
165  2002 [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism]. BALP, BMD, DXM
166  2003 Assessment of bone metabolism in cadmium-induced renal tubular dysfunction by measurements of biochemical markers. bone-ALP, Cd, GFR, intact-BGP, PICP, Pyr, RTD
167  2003 Association between craniofacial growth and urinary bone metabolic markers (pyridinoline, deoxypyridinoline) in growing rats. Pyr
168  2003 Changes in bone turnover markers during 14-day 6 degrees head-down bed rest. ALP, OC
169  2003 Changes in urinary bone resorption markers (pyridinoline, deoxypyridinoline) resulting from experimentally-induced osteoarthritis in the temporomandibular joint of rats. OA, Pyr, TMJ, TMJ-OA
170  2003 Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. BALP, BMD, IL-11, OC, PO, TGF-beta2
171  2003 Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits. BSALP, OC
172  2003 Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. BALP, DEXA, LS-BMD, OC
173  2003 Search for new urinary biochemical markers of collagen degradation in man. CL, glc-gal-pyr, HPLC, Pyr
174  2003 Tail suspension induces bone loss in skeletally mature mice in the C57BL/6J strain but not in the C3H/HeJ strain. ALP, C3H
175  2003 Urinary excretion of deoxypyridinoline increases after gastrointestinal surgery. SIR
176  2003 Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma. AP, OC, Pyr, Ucr
177  2003 [Bone metabolism in adolescent girls with short course of anorexia nervosa]. AN, BGP, BMD, TAP
178  2003 [Changes in the articular compartment in advanced osteoarthritis]. BAP, BS, CA, CHON, OA, Pyr, SF, SM
179  2004 Beneficial effect of etidronate therapy in immobilized hip fracture patients. ---
180  2004 Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. Pyr
181  2004 Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients. BALP, HD, IGF, IGFBP, PTH, Pyr, RDC
182  2004 Relationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women. A-dione
183  2004 The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia. BMD, HA, Pyr, sham
184  2004 The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. PYD
185  2004 TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. anti-TNF-alpha Ab, BFR, BMD, CIA, OPG, RA
186  2004 Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint. HPLC, OA, Pyr, TMJ
187  2005 Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. BGP, BMD, PD, PTH, UPDRS-III
188  2005 Accelerated bone turnover in pregnant women with McCune-Albright syndrome. ALP, CT, Hpr, iOC, iPTH, PTHrP, Pyr
189  2005 Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial. AP, Pyr
190  2005 Clinical correlations of potential activity markers in systemic sclerosis. bET-1, IL-6, NPIIIP, Pyr, sICAM-1, sIL-2r, SSc, sVCAM-1, vWFAg
191  2005 Dietary soy protein and isoflavones: no effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat. BMD, IF, SD
192  2005 Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis. ALP, OC, OC, OC
193  2005 One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. JSW, OA, Pyr, WOMAC
194  2005 The relationship between the zinc nutritive status and biochemical markers of bone turnover in older European adults: the ZENITH study. Pyr
195  2006 Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women. ALP, AVRM, CT, OC, PTH, WE
196  2006 Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. BMD, PD
197  2006 Ingestion of difructose anhydride III, a non-digestible disaccharide, improves postgastrectomy osteopenia in rats. DFAIII, FOS
198  2006 [Calcium and protein intake and bone markers in premenopausic and posmenopausic women with normal bone mineral density from Comodoro Rivadavia (Argentina)]. BAPh, BMD, Ca, CaI, CREA, PrI
199  2006 [Effect of jiangu granule on levels of urinary deoxypyridinoline and osseous intigrin beta1 mRNA expression in Ovariectomized osteoporosis model rats]. ITG beta1, JGG
200  2007 The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. BMD, EPO, OPG, RANKL
201  2009 [Inhibition of soy isoflavone intake on bone loss in menopausal women: evaluated by meta-analysis of randomized controlled trials]. BAP, RCTs, SBMD
202  2010 Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? BMC, BMD, Pyr
203  2011 Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts. BFR, MAR, MS/BS
204  2011 Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard. Gal-Pyr, GluGal-Pyr, Pyr
205  2013 Safety and efficacy of polycalcium for improving biomarkers of bone metabolism: a 4-week open-label clinical study. BALP, Ca, OSC
206  2013 [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats]. AIP, ALP, b-Ca, BMD, Cr, s-P, sCa, U-P, uCa
207  2014 Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin. BMD
208  2014 Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus. QUS, T1DM
209  2017 Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy. BGP, BMD, Cr, FPG, iPTH, OPG, PINP, PIO, Pyr, T2DN, TC, TG, VD
210  2017 Urinary levels of pyridinoline and deoxypyridinoline and bone mineral density in children with type 1 diabetes mellitus. ALP, BMD, DM, PTH, Pyr
211  2018 Effects of the Hormone Replacement Therapy and of Soy Isoflavones on Bone Resorption in Postmenopause. BMD, HRT